Characterization of the interaction of FKBP12 with the transforming growth factor-beta type I receptor in vivo

被引:72
|
作者
Okadome, T
Oeda, E
Saitoh, M
Ichijo, H
Moses, HL
Miyazono, K
Kawabata, M
机构
[1] JAPANESE FDN CANC RES,INST CANC,DEPT BIOCHEM,TOSHIMA KU,TOKYO 170,JAPAN
[2] VANDERBILT UNIV,CTR CANC,NASHVILLE,TN 37232
关键词
D O I
10.1074/jbc.271.36.21687
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The type I transforming growth factor-beta receptor (T beta R-I) is the efferent component of the receptor complex, which presumably phosphorylates intracellular targets. FKBP12, a binding protein for FK506 and rapamycin, is shown to associate with the cytoplasmic region of T beta R-I in vitro. In this report, we investigated the interaction of FKBP12 with T beta R-I in vivo. FKBP12 interacts with T beta R-I in mammalian cells as well as in yeast. Ligand addition does not affect the interaction, and both constitutively active and kinase-negative mutants of T beta R-I bind FKBP12. FKBP12 dissociates from T beta PR-I in the presence of a high concentration of FK506. The juxtamembrane region of T beta R-I, containing the major phosphorylation sites by the type II receptor, is required for the interaction. One of the deletion mutants in this region, which was shown to mediate transcriptional response, does not bind FKBP12, suggesting that FKBP12 is not directly involved in TGF-beta signaling. Furthermore T beta R-I does not phosphorylate FKBP12 in vitro, FKBP12 may not be a direct substrate of T beta R-I but possibly modulates the T beta R-I function through its interaction with the regulatory domain of the kinase.
引用
收藏
页码:21687 / 21690
页数:4
相关论文
共 50 条
  • [21] Type I (RI) and type II (RII) receptors for transforming growth factor-beta isoforms are expressed subsequent to transforming growth factor-beta ligands during excisional wound repair
    Gold, LI
    Sung, JJ
    Siebert, JW
    Longaker, MT
    AMERICAN JOURNAL OF PATHOLOGY, 1997, 150 (01): : 209 - 222
  • [22] Transforming growth factor-beta receptor expression in human cornea
    Joyce, NC
    Zieske, JD
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (10) : 1922 - 1928
  • [23] IMMUNOSUPPRESSION AND TRANSFORMING GROWTH FACTOR-BETA IN GLIOBLASTOMA - PREFERENTIAL PRODUCTION OF TRANSFORMING GROWTH FACTOR-BETA 2
    BODMER, S
    STROMMER, K
    FREI, K
    SIEPL, C
    DETRIBOLET, N
    HEID, I
    FONTANA, A
    JOURNAL OF IMMUNOLOGY, 1989, 143 (10): : 3222 - 3229
  • [24] CHARACTERIZATION OF THE LATENT TRANSFORMING GROWTH FACTOR-BETA COMPLEX IN BONE
    PFEILSCHIFTER, J
    BONEWALD, L
    MUNDY, GR
    JOURNAL OF BONE AND MINERAL RESEARCH, 1990, 5 (01) : 49 - 58
  • [25] Transforming growth factor-beta receptor type I and type II expression during murine hair follicle development and cycling
    Paus, R
    Foitzik, K
    Welker, P
    BulfonePaus, S
    Eichmuller, S
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 109 (04) : 518 - 526
  • [26] Characterization of a 60-kDa cell surface-associated transforming growth factor-beta binding protein that can interfere with transforming growth factor-beta receptor binding
    Piek, E
    Franzen, P
    Heldin, CH
    TenDijke, P
    JOURNAL OF CELLULAR PHYSIOLOGY, 1997, 173 (03) : 447 - 459
  • [27] Crystal structure of the cytoplasmic domain of the type I TGFβ receptor in complex with FKBP12
    Huse, M
    Chen, YG
    Massagué, J
    Kuriyan, J
    CELL, 1999, 96 (03) : 425 - 436
  • [28] Deletion of a Specific Type-I Transforming Growth Factor-beta Receptor Attenuates Thoracic Aortic Aneurysm Development
    Stroud, Robert E.
    Lieser, Sarah L.
    Franklin, Adam N.
    Nadeau, Elizabeth K.
    Mukherjee, Rupak
    Ikonomidis, John S.
    Jones, Jeffrey A.
    CIRCULATION RESEARCH, 2016, 119
  • [29] Multiple and essential Sp1 binding sites in the promoter for transforming growth factor-beta type I receptor
    Ji, CH
    Casinghino, S
    McCarthy, TL
    Centrella, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (34) : 21260 - 21267
  • [30] Regulation of transforming growth factor-beta production by interleukin-12
    Marth, T
    Strober, W
    Seder, RA
    Kelsall, BL
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (05) : 1213 - 1220